Related references
Note: Only part of the references are listed.Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), Amplified on Chromosome 9, Collaborate with p53 Deficiency in Mouse Osteosarcoma Progression
Ou Ma et al.
CANCER RESEARCH (2009)
Positive Cross-Talk between Estrogen Receptor and NF-kB in Breast Cancer
Jonna Frasor et al.
CANCER RESEARCH (2009)
RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1
C. A. Reed et al.
ONCOGENE (2009)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Deborah L. Burkhart et al.
NATURE REVIEWS CANCER (2008)
RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis
Christopher N. Mayhew et al.
GASTROENTEROLOGY (2007)
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer
Xiaoling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Richard S. Maser et al.
NATURE (2007)
Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts
Zongxiang Zhou et al.
CANCER RESEARCH (2007)
RB in breast cancer: At the crossroads of tumorigenesis and treatment
Emily E. Bosco et al.
CELL CYCLE (2007)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
RB family members as predictive and prognostic factors in human cancer
G. Scambia et al.
ONCOGENE (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene
Minjung Kim et al.
CELL (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation
MT Pickering et al.
ONCOGENE (2006)
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development
SWP Wijnhoven et al.
CANCER RESEARCH (2005)
Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy
CN Mayhew et al.
CANCER RESEARCH (2005)
pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia
K Simin et al.
PLOS BIOLOGY (2004)
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
E Hernando et al.
NATURE (2004)
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
Y Minakuchi et al.
NUCLEIC ACIDS RESEARCH (2004)
Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action
MB Sporn et al.
CLINICAL THERAPEUTICS (2004)
Somatic mutation of p53 leads to estrogen receptor α-positive and -negative mouse mammary tumors with high frequency of metastasis
SCJ Lin et al.
CANCER RESEARCH (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene
GW Robinson et al.
ONCOGENE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice -: A model for Li-Fraumeni syndrome
C Kuperwasser et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
RD Cardiff et al.
ONCOGENE (2000)
WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis
ML Li et al.
ONCOGENE (2000)
Share Paper
